Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results
Fernández, M., Narejos, S., Castro, A., Echave-Sustaeta, J., Forner, M., Arana-Arri, E.,…Martínez, S. (2024). Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim … Read More
